Cinthya Parra-Bernal1; Jorge A Aguilera-Partida2; Lauren A Dalvin3; Abelardo A Rodríguez-Reyes4; David Ancona-Lezama1
DOI: 10.5935/0004-2749.20230046
1. Ocular Oncology Service, Institute of Ophthalmology and Visual Sciences, Tecnologico de Monterrey, Monterrey, Mexico
2. Uveitis and Ocular Inflammation Service, Clínica Oftalmológica Santa Lucía, Guadalajara, Jalisco, Mexico
3. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States
4. Ophthalmic Pathology Service, Asociación Para Evitar La Ceguera en México, Hospital Dr. Luis Sanchez Bulnes, Mexico City, Mexico.
David Ancona-Lezama
E-mail: [email protected]